Hang Seng
17,597.61
(-0.22%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,670.13
(0.18%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,403.30
(0.36%)
Lithium
41.42
(1.37%)
Iron Ore
102.75
(-0.71%)
Hang Seng
17,597.61
(-0.22%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,670.13
(0.18%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,403.30
(0.36%)
Lithium
41.42
(1.37%)
Iron Ore
102.75
(-0.71%)
Hang Seng
17,597.61
(-0.22%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,670.13
(0.18%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,403.30
(0.36%)
Lithium
41.42
(1.37%)
Iron Ore
102.75
(-0.71%)
Hang Seng
17,597.61
(-0.22%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,670.13
(0.18%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,403.30
(0.36%)
Lithium
41.42
(1.37%)
Iron Ore
102.75
(-0.71%)
Hang Seng
17,597.61
(-0.22%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,670.13
(0.18%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,403.30
(0.36%)
Lithium
41.42
(1.37%)
Iron Ore
102.75
(-0.71%)
Hang Seng
17,597.61
(-0.22%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,670.13
(0.18%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,403.30
(0.36%)
Lithium
41.42
(1.37%)
Iron Ore
102.75
(-0.71%)
Hang Seng
17,597.61
(-0.22%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,670.13
(0.18%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,403.30
(0.36%)
Lithium
41.42
(1.37%)
Iron Ore
102.75
(-0.71%)
Hang Seng
17,597.61
(-0.22%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,670.13
(0.18%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,403.30
(0.36%)
Lithium
41.42
(1.37%)
Iron Ore
102.75
(-0.71%)
Hang Seng
17,597.61
(-0.22%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,670.13
(0.18%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,403.30
(0.36%)
Lithium
41.42
(1.37%)
Iron Ore
102.75
(-0.71%)
Hang Seng
17,597.61
(-0.22%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,670.13
(0.18%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,403.30
(0.36%)
Lithium
41.42
(1.37%)
Iron Ore
102.75
(-0.71%)
Search
Hang Seng
17,597.61
(-0.22%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,670.13
(0.18%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,403.30
(0.36%)
Lithium
41.42
(1.37%)
Iron Ore
102.75
(-0.71%)
Hang Seng
17,597.61
(-0.22%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,670.13
(0.18%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,403.30
(0.36%)
Lithium
41.42
(1.37%)
Iron Ore
102.75
(-0.71%)
Hang Seng
17,597.61
(-0.22%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,670.13
(0.18%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,403.30
(0.36%)
Lithium
41.42
(1.37%)
Iron Ore
102.75
(-0.71%)
Hang Seng
17,597.61
(-0.22%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,670.13
(0.18%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,403.30
(0.36%)
Lithium
41.42
(1.37%)
Iron Ore
102.75
(-0.71%)
Hang Seng
17,597.61
(-0.22%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,670.13
(0.18%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,403.30
(0.36%)
Lithium
41.42
(1.37%)
Iron Ore
102.75
(-0.71%)
Hang Seng
17,597.61
(-0.22%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,670.13
(0.18%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,403.30
(0.36%)
Lithium
41.42
(1.37%)
Iron Ore
102.75
(-0.71%)
Hang Seng
17,597.61
(-0.22%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,670.13
(0.18%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,403.30
(0.36%)
Lithium
41.42
(1.37%)
Iron Ore
102.75
(-0.71%)
Hang Seng
17,597.61
(-0.22%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,670.13
(0.18%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,403.30
(0.36%)
Lithium
41.42
(1.37%)
Iron Ore
102.75
(-0.71%)
Hang Seng
17,597.61
(-0.22%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,670.13
(0.18%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,403.30
(0.36%)
Lithium
41.42
(1.37%)
Iron Ore
102.75
(-0.71%)
Hang Seng
17,597.61
(-0.22%)
Dow Jones
40,415.44
(0.32%)
Nikkei 225
39,670.13
(0.18%)
FTSE 100
8,198.78
(0.53%)
USD/AUD
0.6690
(-0.32%)
Bitcoin
67,675.89
(-1.09%)
Oil
79.95
(0.21%)
Gold
2,403.30
(0.36%)
Lithium
41.42
(1.37%)
Iron Ore
102.75
(-0.71%)

Recce Pharmaceuticals (ASX:$RCE) awarded overseas r&d finding for synthetic anti-infective development program

Recce Pharmaceuticals (ASX:$RCE) receives significant R&D funding


Recce Pharmaceuticals Ltd (ASX:RCE) has been awarded an Advanced Overseas Finding for AU$43,774,907 of Synthetic Antibiotic Research & Development (R&D) applicable expenditure by AusIndustry, a division of the Australian Government's Department of Industry, Innovation and Science. This finding, one of the largest in Australian history, extends the 43.5% R&D rebate to cover the company's R&D activities worldwide for a period of three years (1 July 2022 to 30 June 2025).

Recce Pharmaceuticals CEO expresses gratitude for government support


Recce Pharmaceuticals CEO James Graham expressed gratitude to AusIndustry and the Department of Industry, Innovation, and Science for their ongoing crucial support in advancing science and its practical applications, particularly in the development of innovative therapies with a global impact. He emphasized that this development is a further endorsement of the Company's growth potential and secures their caveat-free R&D funding long-term.

Recce Pharmaceuticals poised for long-term R&D funding and growth


Recce Pharmaceuticals Ltd (ASX:RCE) has been awarded a significant Advanced Overseas Finding for Synthetic Antibiotic Research & Development (R&D) applicable expenditure by AusIndustry, a division of the Australian Government's Department of Industry, Innovation and Science. This finding extends the R&D cash rebate to cover the company's local and overseas R&D activities for a period of three years, providing long-term support for the company's anti-infective program focused on Synthetic Antibiotic Development. The award, in addition to the recent AUD $11,000,000 capital raise, will bolster the Company's cash position and support its R&D funding facilities. CEO James Graham's expression of gratitude underscores the importance of this finding in securing the company's future R&D funding and growth potential.

Sourcehttps://announcements.asx.com.au/asxpdf/20231214/pdf/05ykskftlwk0wp.pdf

Share to Social
0 Comments
Inline Feedbacks
View all comments

Stock Piper AI Index Coming Soon!

Join our Newsletter to gain exclusive insight and be notified once we are live.

By clicking Subscribe, you agree to our Terms & Conditions

ASX News, First And Fast.

Get all the latest market updates straight to your inbox.

By clicking Subscribe, you agree to our Terms & Conditions